Document Detail


Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu).
MedLine Citation:
PMID:  18214734     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have developed a new home blood pressure (BP) monitoring system by using cellular telephone and the Internet. All data of home BP and pulse rate were directly collected by I-converter date collecting system and sent online to a main server constructed in a central data center. The home doctor can monitor the exercise data of each patient by using this system. This home BP monitoring system was directly connected to the Internet by using application service provider technology (ASP). Anytime and anywhere, each patient can check the changes of these parameters by themselves by using cellular telephone and/or the Internet. The average of the data was calculated and demonstrated online. In real time, all data were monitored and sent to the home doctor's office. In the present study, we tried to use this monitoring system to compare the effect of some antihypertensive drugs on home BP. To compare the effects of telmisartan (TEL) and amlodipine (AM) on home BP, home BP was monitored for eight weeks using this telemedicine system. The target point of office BP was 140/90 mmHg or less. After two weeks control period, telmisartan (TEL group: 20-80 mg/day, n = 21) or amlodipine (AM group: 2.5-10 mg/day, n = 19) was orally administrated once a day in the morning. There was no significant difference of office BP between these two groups. Systolic home BP was significantly decreased from 144 +/- 4 to 134 +/- 3 mmHg (TEL group) and from 143 +/- 4 to 135 +/- 3 mmHg (AM group), respectively. There was no significant difference in the changes of home BP in the morning between groups (eight weeks home systolic BP reduction, TEL: 15 +/- 2 mmHg, AM: 13 +/- 2 mmHg). However the reduction of home BP in the evening in TEL group was significantly bigger than AM group (eight weeks home systolic BP reduction, TEL: 13 +/- 3 vs. AM: 6 +/- 3 mmHg). From these data, we concluded that there is a big difference on the effects of antihypertensive agents on diurnal variation and 24hr overall BP variability in home BP. TEL has a good effect on home BP for 24 hours compared to AM. This telemedicine system has a great advantage in monitoriong home BP correctly in hypertensive patients.
Authors:
Hidetomo Nakamoto; Eiichi Nishida; Munekazu Ryuzaki; Masayoshi Sone; Hiromichi Suzuki; Mitsuo Yoshimoto; Kaoru Itagaki
Related Documents :
25301854 - G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy.
8809594 - Electrocortical responses to ecologically relevant visual stimuli among professional dr...
10826404 - Clinical relevance of office underestimation of usual blood pressure in treated hyperte...
7917144 - Ambulatory blood pressure in diabetic subjects.
24568934 - Characteristics of hypertension subtypes and treatment outcome among elderly korean hyp...
6099734 - Acute and long-term response to enalapril in congestive failure.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  30     ISSN:  1525-6006     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-24     Completed Date:  2008-02-14     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  57-67     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amlodipine / therapeutic use*
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Benzimidazoles / therapeutic use*
Benzoates / therapeutic use*
Blood Pressure / drug effects*
Calcium Channel Blockers / therapeutic use*
Cellular Phone
Female
Humans
Hypertension / prevention & control
Internet / instrumentation
Male
Middle Aged
Self Care / instrumentation*,  methods
Telemedicine / instrumentation*,  methods
Telemetry / instrumentation
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Benzimidazoles; 0/Benzoates; 0/Calcium Channel Blockers; 1J444QC288/Amlodipine; U5SYW473RQ/telmisartan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heart rate variability for evaluating surgical stress and development of postoperative complications...
Next Document:  Involvement of carotid baroreceptor function in blood pressure control in the chronic phase: effect ...